Skip Navigation


Annals of Oncology Advance Access originally published online on July 27, 2006
Annals of Oncology 2007 18(1):198-199; doi:10.1093/annonc/mdl170
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/1/198    most recent
mdl170v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lonning, E
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lonning, E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

letters to the editor

Reply to ‘Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature’ by Delea et al.

E Lonning*

Institute of Medicine Haukeland University Hospital, Department of Oncology, Bergen, Norway

* (E-mail: per.lonning@helse-bergen.no)

The first 10% of the full text of this article appears below.

The letter by Delea et al. [1] raises several interesting questions with respect to cost–utility assessment. In principle, such analyses may be conducted in two different ways: we may calculate utilities based on actual data from the literature, which is the most common practice, or we may do what I did [2], i.e. assume a certain long-term effect and see whether that should provide a reasonable cost–utility estimate. For reasons to be explained below, I believe the second option is of particular value when assessing . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?